Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for depressed teens? pill trial seeks answers

NCT ID NCT07204314

Recruiting now Disease control Sponsor: Takeda Source: ClinicalTrials.gov ↗

Summary

This study is testing whether a daily oral medication called vortioxetine is safe and effective at reducing depression symptoms in Japanese teenagers aged 12 to 17. About 180 participants will be randomly assigned to receive either the real medication or a placebo (a pill with no medicine) for 14 weeks. The main goal is to see if the medication leads to a greater improvement in depression scores compared to the placebo.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Aiiku Clinic

    RECRUITING

    Minato-ku, Tokyo, Japan

  • Bandai Mental Clinic

    RECRUITING

    Chuo-ku, Niigata, Japan

  • Cerisier Heart Clinic

    RECRUITING

    Kagoshima, Japan

  • Chikama Clinic

    RECRUITING

    Miyazaki, Japan

  • Dokkyo Medical University Saitama Medical Center

    RECRUITING

    Koshigaya, Saitama, Japan

  • Harai Clinic

    RECRUITING

    Chuo-ku, Tokyo, Japan

  • Hirosaki University Hospital

    NOT_YET_RECRUITING

    Hirosaki, Aomori, Japan

  • Hokkaido University Hospital

    NOT_YET_RECRUITING

    Sapporo, Hokkaido, Japan

  • Imurokokorono-clinic

    RECRUITING

    Urasoe, Okinawa, Japan

  • Jisenkai Nanko Psychiatric Institute

    RECRUITING

    Shirakawa, Fukushima, Japan

  • Kai Kokoro Clinic

    RECRUITING

    Suginome, Tokyo, Japan

  • Kaku Mental Clinic

    RECRUITING

    Chūōku, Fukuoka, Japan

  • Kanagawa Children's Medical Center

    RECRUITING

    Yokohama, Kanagawa, Japan

  • Kindai University Hospital

    NOT_YET_RECRUITING

    Ōsaka-sayama, Osaka, Japan

  • Kochi Medical School Hospital

    NOT_YET_RECRUITING

    Nankoku, Kochi, Japan

  • Miyakonojo Shinsei Hospital

    RECRUITING

    Miyakonojō, Miyazaki, Japan

  • NHO Shikoku Medical Center for Children and Adults

    RECRUITING

    Zentsujichó, Kagawa-ken, Japan

  • Nagoya City University Hospital

    RECRUITING

    Nagoya, Aichi-ken, Japan

  • Nara Medical University Hospital

    RECRUITING

    Kashihara, Nara, Japan

  • National Center of Neurology and Psychiatry

    NOT_YET_RECRUITING

    Kodaira, Tokyo, Japan

  • Osaka Metropolitan University Hospital

    RECRUITING

    Osaka, Japan

  • Pauroom

    RECRUITING

    Minato-ku, Tokyo, Japan

  • Shin-Otsuka Clinic

    RECRUITING

    Toshima-ku, Tokyo, Japan

  • St. Marianna University School of Medicine Hospital

    NOT_YET_RECRUITING

    Kawasaki, Kanagawa, Japan

  • Tohoku University Hospital

    NOT_YET_RECRUITING

    Sendai, Miyagi, Japan

  • Tokyo Metropolitan Children's Medical Center

    RECRUITING

    Fuchū, Tokyo, Japan

  • Toyama University Hospital

    RECRUITING

    Toyama, Japan

  • University of the Ryukyus Hospital

    RECRUITING

    Ginowan, Okinawa, Japan

  • Yokohama City University Hospital

    RECRUITING

    Yokohama, Kanagawa, Japan

  • Yuge Neuropsychiatric Hospital

    RECRUITING

    Kumamoto, Japan

Conditions

Explore the condition pages connected to this study.

MAJOR DEPRESSIVE DISORDER